ACADIA Pharmaceuticals Inc (ACAD)

Net profit margin

Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020 Mar 31, 2020
Net income (ttm) US$ in thousands 226,451 128,506 30,565 -1,710 -61,286 -148,808 -110,815 -145,940 -215,975 -217,344 -204,618 -214,478 -167,870 -191,536 -261,739 -260,009 -281,584 -267,860 -225,178 -237,978
Revenue (ttm) US$ in thousands 957,797 929,236 890,534 813,806 726,437 631,886 550,901 520,229 517,235 511,503 512,401 493,059 484,145 474,394 463,359 458,241 441,755 419,074 393,083 366,185
Net profit margin 23.64% 13.83% 3.43% -0.21% -8.44% -23.55% -20.12% -28.05% -41.76% -42.49% -39.93% -43.50% -34.67% -40.37% -56.49% -56.74% -63.74% -63.92% -57.29% -64.99%

December 31, 2024 calculation

Net profit margin = Net income (ttm) ÷ Revenue (ttm)
= $226,451K ÷ $957,797K
= 23.64%

ACADIA Pharmaceuticals Inc's net profit margin has exhibited a trend of improvement over the analyzed periods from March 31, 2020, to December 31, 2024. The net profit margin was negative for the initial periods, indicating the company's expenses exceeded its revenues. However, there was a notable turnaround starting from March 31, 2024, where the net profit margin improved significantly to 3.43% and continued to increase further in subsequent quarters.

The positive net profit margins achieved by the company from June 30, 2024, to December 31, 2024, demonstrate a shift towards profitability, with the highest net profit margin of 23.64% recorded at the end of December 31, 2024. This improvement suggests that ACADIA Pharmaceuticals Inc has successfully managed its costs and enhanced its operational efficiency to generate higher profits relative to its revenue.

Overall, the increasing trend in net profit margins indicates that the company has been able to enhance its financial performance and profitability over time, which may be seen as a positive sign for investors and stakeholders.